BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,085,000 | +1692.7% | 104,881 | +1413.2% | 2.90% | +5931.2% |
| Q1 2018 | $451,000 | -72.0% | 6,931 | -72.2% | 0.05% | -66.0% |
| Q4 2017 | $1,612,000 | -73.0% | 24,942 | -73.8% | 0.14% | -78.5% |
| Q3 2017 | $5,970,000 | +2.3% | 95,141 | -1.3% | 0.66% | +9.9% |
| Q2 2017 | $5,834,000 | -99.6% | 96,372 | +233.1% | 0.60% | +585.1% |
| Q1 2017 | $1,500,362,000 | +39053.5% | 28,931 | -66.5% | 0.09% | -61.0% |
| Q4 2016 | $3,832,000 | +1707.5% | 86,425 | +1454.7% | 0.22% | +1211.8% |
| Q4 2015 | $212,000 | -96.4% | 5,559 | -96.9% | 0.02% | -97.0% |
| Q3 2015 | $5,935,000 | +810.3% | 180,672 | +1799.6% | 0.56% | +229.4% |
| Q1 2015 | $652,000 | -40.6% | 9,511 | -43.0% | 0.17% | -49.1% |
| Q3 2013 | $1,097,000 | +105.8% | 16,700 | +117.2% | 0.33% | +93.1% |
| Q2 2013 | $533,000 | – | 7,690 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |